Examkin

Question

Difficulty: HardBias and Confounding in Research

A retrospective cohort study uses an international oncology registry to compare the incidence of severe pneumonitis in non-small cell lung cancer patients treated with a novel immune checkpoint inhibitor versus standard platinum-based chemotherapy. The researchers identify a history of heavy tobacco smoking as a significant confounder. Additionally, previous early-phase trials indicate that a patient's baseline pre-existing autoimmune disease status acts as a strong effect modifier for the relationship between the immune checkpoint inhibitor and the development of pneumonitis. The investigators are outlining their final statistical analysis protocol.

Which of the following analytical approaches are most appropriate for managing the variables of smoking history and pre-existing autoimmune disease in this study? (Select all that apply)

  1. Stratifying the analysis by pre-existing autoimmune disease status and reporting separate relative risks for patients with and without the conditionAnswer
  2. Incorporating tobacco smoking history into a multivariable regression model to calculate an adjusted overall relative risk for pneumonitisAnswer
  3. C
    Adjusting for pre-existing autoimmune disease status in a multivariable regression model to generate a single, unified relative risk estimate
  4. D
    Stratifying the data by tobacco smoking history to demonstrate that the stratum-specific relative risks for pneumonitis are significantly different from one another
  5. E
    Matching patients on pre-existing autoimmune disease status during cohort selection to completely eliminate its impact on the final relative risk calculation

Answer

The most appropriate analytical approaches are stratifying the analysis by pre-existing autoimmune disease status to report separate relative risks, and incorporating tobacco smoking history into a multivariable regression model.
The correct analytical approaches successfully differentiate between the handling of an effect modifier and a confounder. Because pre-existing autoimmune disease is an effect modifier, its interaction with the immune checkpoint inhibitor must be described. This is best accomplished by stratifying the analysis and reporting separate relative risks for patients with and without the condition. Conversely, because smoking history is a confounder, it introduces bias that must be controlled. During the analysis phase, incorporating the confounder into a multivariable regression model effectively adjusts for its influence, providing a more accurate, unconfounded overall relative risk.

Step-by-Step Solution

1
Identify the nature of the variables described in the study design.
Smoking history is identified as a confounder, and pre-existing autoimmune disease is identified as an effect modifier.
Different statistical approaches are required for confounders (which bias results and must be controlled) versus effect modifiers (which represent true biological interactions and must be reported).
2
Determine the appropriate analytical management for a confounder in the analysis phase.
Smoking history should be adjusted for using techniques such as multivariable regression or stratified analysis to yield an unconfounded overall risk estimate.
Controlling for confounding mathematically removes the distorting effect of the third variable on the primary exposure-outcome relationship.
3
Determine the appropriate analytical management for an effect modifier.
Pre-existing autoimmune disease should be analyzed using stratification, where relative risks are calculated and reported separately for patients with and without the condition.
Effect modification is a clinically significant finding. Adjusting or matching it away obscures important biological differences in the drug's safety profile across different patient populations.

Key Concept

In clinical research, confounders are nuisance variables that bias the exposure-outcome association and must be controlled for (e.g., via multivariable regression, matching, or restriction) to find the true effect. Effect modifiers represent a true biological interaction where the exposure's effect differs by the variable's level, and they should be highlighted by reporting stratum-specific results.
Rate this question

Topics

Bias and Confounding in Research

More questions from this topic